Autologous vs Allogeneic Cord Blood Transplant Decision Criteria
Disease biology, not patient preference.
Disease biology, not patient preference.
Banks exploit the timing of cord blood decisions to lock families into uncapped fee increases.
When choosing a specialist, verify their certifications and ask what protocols they actually follow.
The bill extends two federal stem cell programs set to expire in 2026.
Explore burial, art, banking, and other ways to honor the placenta after birth.
Different harvesting methods yield different cell populations, each with tradeoffs.
The first cord blood transplant proved a decade of laboratory theory could save a child's life.
Stem cells in newborn cord blood can treat dozens of serious diseases.
Banked cord blood cannot treat the leukemia mutations that originated before birth.
Perinatal stem cells don't fit neatly into multipotent or pluripotent categories.
The test screens placental DNA, not fetal DNA, and the two don't always match.
AABB accreditation confirms a bank has systems to catch errors, not whether its science is sound.